NDC 55292-304

Tranxene T-Tab

Clorazepate Dipotassium

Tranxene T-Tab is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Recordati Rare Diseases, Inc.. The primary component is Clorazepate Dipotassium.

Product ID55292-304_1aad278c-14c5-4b8a-ad70-ce61a220936e
NDC55292-304
Product TypeHuman Prescription Drug
Proprietary NameTranxene T-Tab
Generic NameClorazepate Dipotassium
Dosage FormTablet
Route of AdministrationORAL
Marketing Start Date1972-06-23
Marketing End Date2023-01-31
Marketing CategoryNDA / NDA
Application NumberNDA017105
Labeler NameRecordati Rare Diseases, Inc.
Substance NameCLORAZEPATE DIPOTASSIUM
Active Ingredient Strength8 mg/1
Pharm ClassesBenzodiazepine [EPC], Benzodiazepines [CS]
DEA ScheduleCIV
NDC Exclude FlagN

Packaging

NDC 55292-304-01

100 TABLET in 1 BOTTLE (55292-304-01)
Marketing Start Date1972-06-23
Marketing End Date2023-01-31
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 55292-304-01 [55292030401]

Tranxene T-Tab TABLET
Marketing CategoryNDA
Application NumberNDA017105
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date1972-06-23

Drug Details

Active Ingredients

IngredientStrength
CLORAZEPATE DIPOTASSIUM7.5 mg/1

OpenFDA Data

SPL SET ID:9c7ab45c-7461-6e4e-ee6d-f0ebe3eb4a28
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 197466
  • 1149627
  • UPC Code
  • 0367386302013
  • Pharmacological Class

    • Benzodiazepine [EPC]
    • Benzodiazepines [CS]
    • Benzodiazepine [EPC]
    • Benzodiazepines [CS]

    NDC Crossover Matching brand name "Tranxene T-Tab" or generic name "Clorazepate Dipotassium"

    NDCBrand NameGeneric Name
    0378-0030Clorazepate Dipotassiumclorazepate dipotassium
    0378-0040Clorazepate Dipotassiumclorazepate dipotassium
    0378-0070Clorazepate Dipotassiumclorazepate dipotassium
    13107-319CLORAZEPATE DIPOTASSIUMCLORAZEPATE DIPOTASSIUM
    13107-320CLORAZEPATE DIPOTASSIUMCLORAZEPATE DIPOTASSIUM
    13107-321CLORAZEPATE DIPOTASSIUMCLORAZEPATE DIPOTASSIUM
    21695-433Clorazepate DipotassiumClorazepate Dipotassium
    21695-434Clorazepate DipotassiumClorazepate Dipotassium
    43063-030Clorazepate Dipotassiumclorazepate dipotassium
    43063-164Clorazepate Dipotassiumclorazepate dipotassium
    43063-350Clorazepate Dipotassiumclorazepate dipotassium
    43063-893Clorazepate DipotassiumClorazepate Dipotassium
    51672-4042Clorazepate DipotassiumClorazepate Dipotassium
    51672-4043Clorazepate DipotassiumClorazepate Dipotassium
    51672-4044Clorazepate DipotassiumClorazepate Dipotassium
    60505-4754Clorazepate DipotassiumClorazepate Dipotassium
    55292-304Tranxeneclorazepate dipotassium

    Trademark Results [Tranxene]

    Mark Image

    Registration | Serial
    Company
    Trademark
    Application Date
    TRANXENE
    TRANXENE
    72319593 0901420 Live/Registered
    ETABLISSEMENTS CLIN-BYLA
    1969-02-19

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.